Skip to main content

Neonatal Abstinence Syndrome (NAS): What You Need to Know

Page 1

Health & Wellness

extension.usu.edu/HEART May 2023

Neonatal Abstinence Syndrome (NAS): What You Need to Know Maren Wright Voss, Amelia Van Komen, Emily Hamilton, Aarica Cleveland, Jaclyn Miller

National overdose deaths continue to rise, with 2021 marking the first time U.S. overdose deaths topped 100,000 in a 12-month timeframe. Substance use, such as alcohol, cocaine, opioids, and marijuana, during pregnancy is also increasing.1 As the U.S. struggles with harmful substance use, a growing number of infants are born with neonatal abstinence syndrome (NAS), a harmful outcome of fetal exposure to substances.2 This fact sheet will talk about why and what to do, with recommendations for safe treatment and support during pregnancy.

7% of females report opioid use during pregnancy, and 21% of those report misuse of opioids.19

In the U.S., one newborn is diagnosed with NAS every 24 minutes.20 What Is Neonatal Abstinence Syndrome (NAS)? NAS is the cluster of withdrawal symptoms infants experience after birth caused by exposure to substances in utero.3 All opioids can cause NAS, including illegal drugs like heroin, prescription drugs like oxycodone or fentanyl, and drugs used for treating opioid use disorder.4,5 irritability, sweating, sneezing, fevers, yawning, low birth weight, heart defects

difficulty feeding, increased muscle tone, tremors, jitteriness, diarrhea, short sleep cycles

Symptoms of NAS4,5,6

Females who have a substance use disorder (SUD) can have social, psychological, and medical histories that may present risk factors affecting the health of the pregnancy and the infant.7


Turn static files into dynamic content formats.

Create a flipbook
Neonatal Abstinence Syndrome (NAS): What You Need to Know by Utah State University Extension - Issuu